SCHEDULE 13GAccepted Sep 21, 4:09 PM ET
Aclaris Therapeutics, Inc. SCHEDULE 13G
Accepted (ET)
4:09 PM
Sep 21, 2026
Filed
Sep 21, 2026
Documents
2
Size
29.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.